Anti-aging supplements taken by millions may undermine cancer treatment, study warns

A study found that NAD+-boosting supplements including NMN and nicotinamide riboside may reduce the effectiveness of chemotherapy in pancreatic cancer cells. Researchers observed that these supplements, which are widely used by consumers, appeared to protect cancer cells from treatment in laboratory testing. The study was published in a peer-reviewed journal and examined how common supplements interact with cancer therapies.

Next story